scholarly journals Transgenic Flavonoid Tomato Intake Reduces C-Reactive Protein in Human C-Reactive Protein Transgenic Mice More Than Wild-Type Tomato

2006 ◽  
Vol 136 (9) ◽  
pp. 2331-2337 ◽  
Author(s):  
Dietrich Rein ◽  
Elio Schijlen ◽  
Teake Kooistra ◽  
Karin Herbers ◽  
Lars Verschuren ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Xian-Zhen Hu ◽  
Tyler T. Wright ◽  
Nicholas R. Jones ◽  
Theresa N. Ramos ◽  
Gregory A. Skibinski ◽  
...  

We showed earlier that experimental autoimmune encephalomyelitis (EAE) in human C-reactive protein (CRP) transgenic mice (CRPtg) has delayed onset and reduced severity compared to wild-type mice. Since human CRP is known to engage Fc receptors and Fc receptors are known to play a role in EAE in the mouse, we sought to determine if FcRI, FcRIIb, or FcRIII was needed to manifest human CRP-mediated protection of CRPtg. We report here that in CRPtg lacking either of the two activating receptors, FcRI and FcRIII, the beneficial effects of human CRP are still observed. In contrast, if CRPtg lack expression of the inhibitory receptor FcRIIB, then the beneficial effect of human CRP is abrogated. Also, subcutaneous administration of purified human CRP stalled progression of ongoing EAE in wild-type mice, but similar treatment failed to impede EAE progression in mice lacking FcRIIB. The results reveal that a axis is responsible for protection against EAE in the CRPtg model.


2016 ◽  
Vol 473 (9) ◽  
pp. 1215-1224 ◽  
Author(s):  
Jie Li ◽  
Dong Wei ◽  
Mark A. McCrory ◽  
Alexander J. Szalai ◽  
Gangyi Yang ◽  
...  

Defective central leptin signalling and impaired leptin entry into the CNS (central nervous system) represent two important aspects of leptin resistance in obesity. In the present study, we tested whether circulating human CRP (C-reactive protein) not only diminishes signalling of leptin within the CNS, but also impedes this adipokine's access to the CNS. Peripheral infusion of human CRP together with co-infused human leptin was associated with significantly decreased leptin content in the CSF of ob/ob mice. Furthermore, following peripheral infusion of human leptin, the CSF (cerebrospinal fluid) concentration of leptin in transgenic mice overexpressing human CRP was sharply lower than that achieved in similarly infused wild-type mice. Administration of LPS (lipopolysaccharide) to human CRP-transgenic mice dramatically elevated the concentrations of human CRP in the CSF. The i.c.v. (intracerebroventricular) delivery of human CRP into the lateral ventricles of ob/ob mice blocked the satiety and weight-reducing actions of human leptin, but not those of mouse leptin. I.c.v. injection of human CRP abolished hypothalamic signalling by human leptin, and ameliorated the effects of leptin on the expression of NPY (neuropeptide Y), AgRP (Agouti-related protein), POMC (pro-opiomelanocortin) and SOCS-3 (suppressor of cytokine signalling 3). Human CRP can impede the access of leptin to the CNS, and elevation of human CRP within the CNS can have a negative impact on the physiological actions of leptin.


1995 ◽  
Vol 73 (6) ◽  
pp. 521-531 ◽  
Author(s):  
CAROL S LIN ◽  
DONGYUAN XIA ◽  
JEUNG S YUN ◽  
THOMAS WAGNER ◽  
TERRY MAGNUSON ◽  
...  

2003 ◽  
Vol 4 (2) ◽  
pp. 334
Author(s):  
H. Princen ◽  
B.-J. De Rooij ◽  
A.J. Szalai ◽  
M. De Maat ◽  
T. Kooistra ◽  
...  

CHEST Journal ◽  
1994 ◽  
Vol 105 (3) ◽  
pp. 101S-101 ◽  
Author(s):  
R. O. Webster ◽  
R. Heuertz ◽  
D. Xia ◽  
D. Samols

1995 ◽  
Vol 25 (12) ◽  
pp. 3489-3495 ◽  
Author(s):  
Thomas C. Klein ◽  
Rainer Döffinger ◽  
Mark B. Pepys ◽  
Ulrich Rüther ◽  
Bruno Kyewski

2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
Tyler T Wright ◽  
Rachel V. Jimenez ◽  
Todd E. Morgan ◽  
Namrata Bali ◽  
Xiaogang Hou ◽  
...  

We recently demonstrated that human C-reactive protein (CRP), expressed hepatically in transgenic mice (CRPtg), improved the outcome of experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS). The liver is the primary site of CRP synthesis in humans and in CRPtg mice but is also expressed by both at low levels in the CNS. To determine if CNS expression of human CRP is sufficient to impact EAE, we generated neuronal CRP transgenic mice (nCRPtg) wherein human CRP expression is driven by the neuron-specific Ca2+/calmodulin-dependent protein kinase IIα(CaMKIIα) gene promoter. We found that hepatically expressed/blood-borne CRP, but not CNS expressed CRP, lessened EAE severity. These outcomes indicate that the protective actions of human CRP in EAE are manifested in the periphery and not in the CNS and reveal a previously unappreciated site specificity for the beneficial actions of CRP in CNS disease.


2012 ◽  
Vol 1 ◽  
pp. e52 ◽  
Author(s):  
Nicholas R Jones ◽  
Melissa A Pegues ◽  
Mark A McCrory ◽  
Walter Singleton ◽  
Claudette Bethune ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document